Results 11 to 20 of about 926 (210)
Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review
Frontiers in Pharmacology, 2023 Obesity is fast growing as a global pandemic and is associated with numerous comorbidities like cardiovascular disease, hypertension, diabetes, gastroesophageal reflux disease, sleep disorders, nephropathy, neuropathy, as well as asthma.
Aparoop Das +4 more
doaj +1 more source
Cardiovascular Diabetology, 2022 Obesity is characterized by visceral fat accumulation and various metabolic disturbances that cause metabolic syndrome and obesity-related cardiovascular diseases (ORCVDs). Hence, treatments targeting obesity should also prevent ORCVDs.
Kosuke Sawami +2 more
doaj +1 more source
Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities
Pharmaceutics, 2022 Obesity is a global public health issue that results in many health complications or comorbidities, including type 2 diabetes mellitus, cardiovascular disease, and fatty liver. Pharmacotherapy alone or combined with either lifestyle alteration or surgery
Jing Li +4 more
doaj +1 more source
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
Frontiers in Endocrinology, 2023 Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors. In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making it ...
Jing-Yue Wang +7 more
doaj +1 more source
Current and upcoming methods of pharmacotherapy of obesity
Journal of Education, Health and Sport, 2023 Introduction and purpose: Obesity remains an urgent problem, both worldwide and in Poland. Approximately 25% of people in Poland are obese. Therefore, anti-obesity drugs are gaining clinical importance.
Jan Bieniasz +4 more
doaj +1 more source
Marine Algae as a Potential Source for Anti-Obesity Agents
Marine Drugs, 2016 Obesity is a major epidemic that poses a worldwide threat to human health, as it is also associated with metabolic syndrome, type 2 diabetes and cardiovascular disease. Therapeutic intervention through weight loss drugs, accompanied by diet and exercise,
Chu Wan-Loy, Phang Siew-Moi
doaj +1 more source
Frontiers in Endocrinology, 2023 IntroductionPharmacological therapy is recommended as a second-line alternative to reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. The aim of this
Yan Xue +9 more
doaj +1 more source
Pharmacotherapeutic options for the management of obesity in children [PDF]
Journal of Advanced Biomedical and Pharmaceutical Sciences, 2023 Obesity in children has increased dramatically over the past few decades, becoming a major public health concern worldwide. Effective treatments must be implemented to reduce the burdens related to diabetes, cardiovascular disease, and mortality ...
Ahmed Aldhafiri
doaj +1 more source
Obesity Drug Update: The Lost Decade?
Pharmaceuticals, 2010 The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the ...
Fayi Yao, Robert George MacKenzie
doaj +1 more source
Obesity–An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances
Biomolecules, 2021 Obesity represents a major public health problem with a prevalence increasing at an alarming rate worldwide. Continuous intensive efforts to elucidate the complex pathophysiology and improve clinical management have led to a better understanding of ...
Erind Gjermeni +9 more
doaj +1 more source